Over the past five years, Ascent Strategic Communications has partnered across the rare disease ecosystem, working alongside advocacy organizations, coalitions, emerging and commercial-stage biotech companies, and specialized pharmacy and service providers. While each organization operates with distinct goals, they share a common challenge: how to communicate with clarity, credibility, and compassion in an environment where every word carries weight.
Ascent’s work reflects the reality that no single tactic can move the needle in this space. We have developed and executed integrated strategies that connect corporate objectives with community needs, ensuring that communications are both impactful and responsible. In most cases, we are directly connected to the senior leadership team and are aligned to their priority goals, but we have also been activated specifically for advocacy campaigns or marketing initiatives.
Our work spans:
At every stage, our role has been to ensure that communications are not only strategic, but deeply human, and deeply impactful.
One of the most nuanced aspects of rare disease communications is balancing two equally important perspectives: the patient experience and the corporate responsibility to operate within regulatory and policy frameworks.
Ascent can serve as a bridge between these worlds. We work to elevate authentic patient stories without overstepping compliance boundaries. We help companies communicate scientific progress with clarity, without losing sight of the individuals behind the data. And we guide organizations through policy-sensitive environments where messaging must be precise, credible, and defensible.
This is where execution meets judgment, trust, and true knowledge of the landscape.
Our impact is driven in part by the strength of our relationships. Over time, we have built trusted connections across:
These relationships allow us to place stories that resonate beyond headlines, shaping broader narratives around disease awareness, innovation, and access.
We approach every engagement as a long-term partnership, not a series of transactions. That means:
When working with a rare disease-focused company, the stakes are high and timelines are often unpredictable. Our role is to bring clarity and momentum, even in the most complex and fast-moving situations.
The results of this work extend far beyond traditional communications metrics.
Perhaps most importantly, this work has helped bring visibility to conditions that have historically been overlooked, ensuring that patients and families feel seen, heard, and supported.
Our commitment to rare disease is both strategic and deeply personal. We are drawn to this space because it demands the very best of communications: clarity in complexity, empathy in storytelling, and discipline in delivery. It challenges us to think beyond traditional models and to operate with a level of care and responsibility that is unmatched in other sectors.
At the same time, Ascent is not defined solely by healthcare. Our broader experience across industries allows us to bring fresh thinking, creative approaches, and new models of engagement into rare diseases, helping organizations break through in meaningful ways.
This combination of deep specialization and expansive perspective is what enables us to drive real impact.
At Ascent, we are proud to play a role in advancing rare disease awareness, supporting innovation, and strengthening the connection between science and the people it is meant to serve.
